Covid-19 man­u­fac­tur­ing roundup: Scot­tish gov­ern­ment in­vests $27M in Val­neva's Covid-19 man­u­fac­tur­ing; Mod­er­na part­ners with Latin Amer­i­can phar­ma

Val­ne­va’s Scot­tish unit has re­ceived a $27 mil­lion grant to fund the R&D of man­u­fac­tur­ing its Covid-19 vac­cine VLA2001.

The in­vest­ment …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.